Infignos Media -- buyersUSA Consulting
NOW PLAYING
15 Radio Streams
Click Here
buyersUSA Consulting
Advertise Here

From Government, Legal and Policy - Legal Issues

Brought to you by ERA King Real Estate

We bring the world to Alabama's doorstep. Offices in Birmingham, Anniston, Gadsden, and Lincoln. Call us at 256-831-5656 or visit us at eraking.com.

Erectile Dysfunction

CRESTOR US Patent Upheld by Court of Appeals for the Federal Circuit

Mon, 17 Dec 2012 10:47:29 EST

AstraZeneca announced today that the Court of Appeals for the Federal Circuit has upheld the decision of the District Court, District of Delaware, finding that the US substance patent protecting CRESTOR (rosuvastatin calcium) (RE37,314 – the '314 patent) is valid and enforceable. The defendants may seek a rehearing and/or review by the U.S. Supreme Court. Absent a reversal of this decision, none of the Abbreviated New Drug Applications (ANDAs) filed by Apotex, Aurobindo, Cobalt, Glenmark, Mylan, Par, Sandoz, Sun, Teva and Torrent may be approved by the FDA prior to expiration of the '314 patent. The '314 patent, which expires in 2016, covers rosuvastatin calcium, the active ingredient in CRESTOR.

The Federal Circuit also held that Apotex Corp. was liable as a submitter and is therefore bound by the District Court's decision.

NOTES TO EDITORS

About the Trial

Beginning in 2007, nine generic drug manufacturers filed ANDAs along with Paragraph IV certifications of non-infringement, invalidity, or unenforceability with respect to the CRESTOR '314 substance patent. AstraZeneca and Shionogi (the owner of the '314 patent) filed patent infringement suits against eight manufacturers (various parent or subsidiary entities of Apotex, Aurobindo, Cobalt, Mylan, Par, Sandoz, Sun and Teva) who had challenged the '314 substance patent. These suits were consolidated by order of the Judicial Panel on Multidistrict Litigation and tried in the U.S. District Court, District of Delaware. Trial commenced on February 22, 2010 before Judge Farnan and ended on March 3, 2010.

In June 2010, the US District Court for the District of Delaware found the '314 patent valid and enforceable and infringed by the eight generic defendants.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com.


Source: WebWire



From Our Blogs

Tips for Beating the Winter Blues

Many people find that the dark and cold days can impact their mood.

Healthy Winter Skin Care Tips

Cool temperatures, low humidity, and furnace-blasted dry air can leave your skin dry.

Holiday Gift Ideas for the Health Conscious

Americans have a lot on their minds during the holiday season.

Don’t Let Kids' Brains Go on Vacation During the Holiday Season

You can help dampen this effect by making sure kids use their brains over the holidays.


Sign up for our weekly newsletter.

Our Website Sponsors

Tangible Investment Group

Since 2006 we've been buying your gold and jewelry. Highest Prices Guaranteed, and you can take that to the bank! Located on 5th floor in Wells Fargo Bank Building, Quintard Ave. Anniston. Call us at 256-231-0444.

Batteries Unlimited

Your local source for just about every battery you can imagine. Call us first at 256-238-9005.

Doc's Furniture

Good used furniture,antiques & collectibles. Located on the corner of Hwy 202 & 300 1st Ave. W. (Anniston) Open Mon-Sat 9-5. Call 256-310-8223

Sunny King Ford

We offer new Ford cars, trucks, SUVs and crossovers online at www.sunnykingford.com. Call 256-831-5300.

Valley Heating and Cooling

It's hard to stop a Trane. Your local heating and cooling company. Located in Saks at 521 Post Oak Road. Call us at 256-820-3369.